- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 26.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 23.91M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 12.38M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $8K |
| Capex | Q1 2026 · Mar 31, 2025 | $16K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.24M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$8.9M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $37.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $29.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $37.7M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $30.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $11.27M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $7.43M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $26.49M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $18.94M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $26.7M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $18.94M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $63.55M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $48.96M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $64.41M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $49.14M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.54 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.50 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.54 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.04 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.61M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2.17M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$12.82M |
| Net Income | Q1 2026 · Mar 31, 2025 | $570K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.44M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$7.99M |